Lipid Profile Changes in Pregnant Women with Pre-Eclampsia and Their Correlation with Severety of Pre-Eclampsia


  • Niran Kamel*, Wasan Munim Al-Imamein Al Kadhimein Medical City
  • Wasan Munim Al-Hakeem General Hospital
  • Alaa Raheem Kareem Al-Imamein Al Kadhimein Medical City
  • Mustafa Rasool Hussein Aal-Saleh Baghdad Teaching Hospital
  • Mohammed Luay Subhi Al-Imamein Al Kadhimein Medical City
  • Sarah Abdulkareem Ali Al-Dujaili Al-Imamein Al Kadhimein Medical City



: Lipid profile, pregnancy, severe pre-eclampsia


Objectives: To find out whether there is a lipid profile changes in pregnant women with preeclampsia and if we can use these lipid profile changes as markers of the severity of preeclampsia (for follow up to avoid leaving the patient reaching ecplamptic stage).


Design: A prospective case-control study.

Setting: AL- Kadhimiya Teaching hospital/department of Obstetrics and Gynecology.

Materials and Methods: The study included 120 pregnant women in the third trimester. They were divided into three groups. The study group consists of 60 preeclamptic and eclamptic women, 25 women had mild pre-eclampsia and 35 women with severe preeclampsia. The control group consists of 60 normotensive pregnant women. Blood sample was drown after 8-10 hours fasting. Triglyceride, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol and very low-density lipoprotein cholesterol levels were measured.

Results: Triglyceride and VLDL-C level of severe Preeclampsia group and mild Preeclampsia group was higher than the control group, but the difference between the severe PE group and the control group was statistically significant (p<0.05). Serum cholesterol in the severe PE group was significantly higher than in mild PE group and in the control group (p<0.05). LDL-C and HDL-C levels were determined similarly in all groups (p>0.05). A highly significant positive correlation between the level of proteinuria and serum cholesterol levels, LDL-C, TG and VLDL-C levels. While there was significantly negative correlation between proteinuria and HDL-C levels. Also, a significant positive correlation between the systolic-tension and serum cholesterol levels, TG, VLDL-C levels and among the diastolic-tension and with LDL-C, TG, VLDL-C levels.

Conclusion: Changes in levels of lipid profile are related with preeclampsia, especially with severe preeclampsia.


- Miller DA. Hypertension in Pregnancy. In Decherney AH, Nathan L, Goodwin TM, et al (eds.): Current Diagnosis and Treatment Obstetrics and Gynaecology. 14th ed. McGraw Hill publisher 2018; chapter19: 318-327.

- Sibai BM. Hypertensive diseases in pregnancy. In: Reece EA, Hobbins JC and Gant NF. Clinical Obstetrics the Fetus & Mother. Blackwell third edition, 2017; 38: 683-699.

- Castro LC. Hypertensive disorder of pregnancy. In: Hacker N F, Janbone J C, Hobel C J, eds: Essential of Obestetrics and Gynaecology 8th edition. Elsevier publishing, 2018; chapter 14:173-182.

- Hubel CA. Oxidative Stress in Pathogenesis of preeclampsia. P.S.E.B.M.1999; 222: 222-235.

- Martínez ADH, Ortega RP, Opazo RB, et al. Hyperlipidemia during gestational diabetes and its relation with maternal and offspring complications. Nutr Hosp 2018; 35:698-706. DOI: 10.20960/nh.1539

- Drevon CA, Endressen MJ, HenriksenT. Fatty acid pattern of esterfied and free fatty acids in sera of women with normal and preeclamptic pregnancy. Br J Obstet Gynaecol. 2015; 102:530-537.

- Kumar S and Kavitha B. Comparison of Abnormal Lipid Profile in Normotensive and Hypertensive Women during Pregnancy and its Significance. J Gynecol Women’s Health 8(1): JGWH.MS.ID.555728 (2018)

- McLaughlin MK, Evans RW, et al. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post-partum. Am J Obstet Gynecol 2016; 174: 975–82.

- Berry C, Sattar N, Bendomir A, et al. Lipoprotein subfractions in pre-clampsia: pathogenic parallels to atherosclerosis. Obstet Gynecol 2017; 89: 403–8.

- Kaaja R. Insulin resistance syndrome in preeclampsia. Sem Reprod Endocrinol 1998; 16: 41-46.

- Mittal M, Kulkarni CV, Panchonia A, Mittal RK. Evaluation of

serum lipid profile in cases of preeclampsia and eclampsia. Int J Reprod

Contracept Obstet Gynaecol. (2014) 3(3): 732-734.

- El Khouly NI, Sanad ZF, Saleh SA, et al. Value of first trimester serum lipid profile in early prediction of preeclampsia and its severity: A prospective cohort study. Hypertens Pregnancy, (2016), 35(1):73-81.

- American College of Obstetricians and Gynecologists, Task force on hypertension in pregnancy. Report of the American college of obstetricans and gynecologists' task force on hypertension in pregnancy. Obstet Gynecol. (2013), 122(5): 1122-31.

- Shennan A. Pre-eclampsia and non proteinuric pregnancy-induced hyper-tension. In Luesley MD, Baker NP, Cardozo L, et al (eds): Obstetrics and Gynaecology an evidence-based text for MRCOG. 4th ed. Arnold (publishers) Ltd 2018; 184-191.

- Bouet PE, Gillard P, Descamps P, Sentilhes L. Management of pre- eclampsia. Rev Prat. 2014;64(1145–1149):1151-1142.

- Subramaniam S, Fahy E, Gupta S, et al. "Bioinformatics and Systems Biology of the Lipidome". Chemical Reviews 2011; 111 (10): 52–90.

- Lecarpentier E, Haddad B, Goffinet F, Tsatsaris V. Medical approaches for managing preeclampsia. Presse Medicale. 2016; 45:638-645.

- Karumanchi SA, Stillman IE, Lindheimer MD: Angiogenesis and preeclampsia. In Lindheimer MD, Roberts JM, Cunningham FG (eds): Chesley's Hypertensive Disorders of Pregnancy, 3rd ed. New York, Elsevier, In press, 2009, p 87

- van de Woestijne AP, was sink AM, Monajemi H, et al. Plasma tri-glyceride levels increase the risk for recurrent vascular events in-dependent of LDL- cholesterol or nonHDL- cholesterol. Int J Cardiol. 2013; 167:403-408

- Turner JA: Diagnosis and management of pre-eclampsia, In: an update in International Journal of Women’s Health ,2010;2 :327–337

- Sharami SH, Ranjbar ZA, Alizadeh F, Kazemnejad E. The relationship of hyperlipidemia with maternal and neonatal outcomes in pregnancy: A cross-sectional study. International Journal of Reproductive BioMedicine. 2019,17:10, ijrm.v17i10.5294

- Adiga Usha, Adiga Sachidananda. Dyslipidemia in Pregnancy Induced Hypertention. JGPT, 2009, 96-72.

- Rubina Aziz, Tabassum Mahboob. Pre-eclampsia and lipid profile. Pak J Med Sci October - December 2017 (Part-I), 23(5): 751-754.

- Ahmed AZM, El Omda FAA and Mousa MSM. Maternal Lipid Profile as A Risk Factor for Preeclampsia. The Egyptian Journal of Hospital Medicine (2018)71 (6),3434-3438.

- Valmir Jose de Lima, Claudia Roberta de Andrade, Gustavo Enrico Ruschi, Nelson Sass. Serum lipid levels in pregnancies complicated by pre-eclampsia. Sao Paulo Med. J. Mar. 2011;129(2) :73-6.

- Lei Q, Zhang B Y, Wen J Y, et al. Ante-partum and post-partum markers of metabolic syndrome in pre-eclampsia. Journal of Human Hypertension 2011; 25: 11–17.

- Ray JG, Diamond P, Singh G, Bell CM. Brief overview of maternal triglycerides as a risk factor for pre-eclampsia. BJOG. 2006; 113:379-86.

- Punthumapol C, Kittichotpanich B. Comparative study of serum lipid concentrations in preeclampsia and normal pregnancy. J Med Assoc Thai. 2008 Jul;91(7):957-61.

- Madhusudan D, Devendra A, Nagarja N, Reema K. Serum cholesterol and ceruloplasmin levels in second trimester can predict development of pre- eclampsia. N Am J Med Sci. 2013; 5:41.

- Spracklen, CN, et al., Maternal hyperlipidemia and the risk of preeclampsia: a meta-analysis. Am J Epidemiol, 2014. 180(4): p. 346-58.

- Gohil JT, Patel PK, Priyanka Gupta. Estimation of Lipid Profile in Subjects of Preeclampsia. J Obstet Gynaecol India 2011 August; 61(4): 399–403.

- Sahu S, Abraham R, Vedavalli R, Daniel M. Study of lipid profile, lipid peroxidation and vitamin E in pregnancy induced hypertension. Indian J Physiol Pharmacol 2009 Oct-Dec;53(4):365-9.

- Uzun H, Benian A, Madazli R, et al. Cerculating Oxidized Low- Density Lipoprotien and paraxonase Activity in preeclampsia Gynecol. Obstet invest: 2005 :60:195-200.

- Islam NAF, Chowdhury MAR, Kibria GM, Akhter S. Study of Serum Lipid Profile in Pre-Eclampsia and Eclampsia. Faridpur Med. Coll. J. 2010;5(2):56-59.

- Sena, CM, Pereira AM, Seica R. Endothelial dysfunction - a major mediator of diabetic vascular disease. Biochim Biophys Acta, 2013. 1832(12): p. 2216-31.

- Jayanta D., Ananda K.M. and Pradip K.S. Study of serum lipid profile in pregnancy induced hypertension. Indian J. Clin. Biochem. 2006;21: 165-168.

- Uzan, J, et al., Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag, 2011. 7: p. 467-74

- Bradley R, Crook D. Pregnancy, oral contraception and hormone replacement therapy, In: Marshall, W.J. and Bangert, S.K. Eds. Textbook of Clinical Biochemistry: Metabolic and Clinical aspects, 8th edition, London, Churchill Livingstone, 2015; p 413-22

- Kaaja R, Tirkkanen MJ, Viinnkka L, Ylikorkala O. Serum lipoproteins, insulin and urinary prostanoid metabolites in normal and hypertensive pregnant women, Obstet. Gynecol. 2015; 85(3):353-6.